antiarrhythmic pharmacotherapy during SARS-COV-2 pandemic

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorMeltzer, Maya Di
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentdeptUniversity of Debrecen, Kenézy Gyula Campus Department of Anaesthesiology and Intensive Carehu_HU
dc.contributor.opponentdeptUniversity of Debrecen, Department of Pharmacology and Pharmacotherapyhu_HU
dc.date.accessioned2021-05-16T07:11:10Z
dc.date.available2021-05-16T07:11:10Z
dc.date.created2021-03-08
dc.description.abstractThis thesis offers a review of antiarrhythmic drugs with an emphasis on antiarrhythmic therapy during SARS-CoV-2 pandemic. Includes the general mechanisms causing arrhythmias with and without SARS-CoV-2 infection. in addition, drug-drug interactions between antiarrhythmics and drugs used in COVID-19 therapy are demonstrated, and the option of repurposing antiarrhythmic drugs for use against SARS-CoV-2 is discussed as well. to sum up, this is a comprehensive review of the pharmacological aspects of treating patients suffering from both rhythm abnormalities, and COVID-19.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangmagyarhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent37hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/309663
dc.language.isoenhu_HU
dc.subjectantiarrhythmicshu_HU
dc.subjectSARS-CoV-2hu_HU
dc.subjectCOVID-19hu_HU
dc.subjectdrug interactionshu_HU
dc.subject.dspacepharmacologyhu_HU
dc.titleantiarrhythmic pharmacotherapy during SARS-COV-2 pandemichu_HU
Fájlok